MCE
SB 202190
SB 202190
SB 202190 is a selective p38 MAP kinase inhibitor with IC50s of 50 nM and 100 nM for p38α and p38β2, respectively. SB 202190 binds to the ATP pocket of the active recombinant human p38 kinase with a Kd of 38 nM. SB 202190 has anti-cancer activity and rescued memory deficits. SB202190 induces autophagy.
Couldn't load pickup availability
General Specifications
1) Purity: 99.89%2) Molecular Weight: 331.34
3) Formula: C20H14FN3O
4) CAS No.: 152121-30-7
5) Appearance: Solid
6) Color: Light yellow to yellow
7) SMILE: FC1=CC=C(C2=C(C3=CC=NC=C3)NC(C4=CC=C(O)C=C4)=N2)C=C1
8) Shipping: Room temperature in continental US; may vary elsewhere.
9) Storage: Powder: -20°C, 3 years ; 4°C, 2 years ; In solvent: -80°C, 2 years ; -20°C, 1 year
Safety & Documentation
Error in entry: 1) Datasheet, https://cdn.shopify.com/s/files/1/0716/2553/9802/files/Datasheet_HY-10295.pdf?v=1734506157 , 2) MSDS, https://cdn.shopify.com/s/files/1/0716/2553/9802/files/MSDS_HY-10295.pdf?v=1734506828 , 3) Handling Instruction, https://cdn.shopify.com/s/files/1/0716/2553/9802/files/Handling_Instructions_HY-10295.pdf?v=1734506808
{# This line will help debug any improperly formatted entries #}
Disclaimer: Products are chemical reagents for research use
only and are not intended for human use. We do not sell to patients.